Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;35(6):40-43.

Nephrogenic Systemic Fibrosis in a Patient With Multiple Inflammatory Disorders

Kelley Chuang  1 , Casey Kaneshiro  1 , Jaime Betancourt  1
Affiliations

Nephrogenic Systemic Fibrosis in a Patient With Multiple Inflammatory Disorders

Kelley Chuang et al. Fed Pract. 2018 Jun.

Abstract

The risk of developing nephrogenic systemic fibrosis in patients with end stage renal disease may increase with exposure to gadolinium-based contrast dyes during magnetic resonance imaging.

PubMed Disclaimer

Conflict of interest statement

Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.

Figures

FIGURE 1
FIGURE 1
Skin Thickening on Forearm Black arrows indicate areas of skin thickening; white arrow indicates a pyoderma gangrenosum lesion.
FIGURE 2
FIGURE 2
Haematoxylin and Eosin Stain, 4x Magnification of Fibrotic Tissue in the Deep Dermis Arrows indicate haemotoxylin and eosin stain (4×) showing bands of fibrotic tissue in the deep dermis; 1 shows normal subcutaneous adipose tissue; 2 indicates reticular dermis.
FIGURE 3
FIGURE 3
Haematoxylin and Eosin Stain, 4× Magnification of Dermal Fibrosis Arrows indicate haemotoxylin and eosinstain (4×) showing dermal fibrosis with thick collagen deposition.
See this image and copyright information in PMC

References

    1. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet. 2000;356(9234):1000–1001. - PubMed
    1. Todd DJ, Kagan A, Chibnik LB, Kay J. Cutaneous changes of nephrogenic systemic fibrosis. Arthritis Rheum. 2007;56(10):3433–3441. - PubMed
    1. Zhang B, Liang L, Chen W, Liang C, Zhang S. An updated study to determine association between gadolinium-based contrast agents and nephrogenic systemic fibrosis. PLoS One. 2015;10(6):e0129720. - PMC - PubMed
    1. Wermuth PJ, Del Galdo F, Jiménez SA. Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents. Arthritis Rheum. 2009;60(5):1508–1518. - PMC - PubMed
    1. Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H. Current status of nephrogenic systemic fibrosis. Clin Radiol. 2014;69(7):661–668. - PubMed

LinkOut - more resources